Turn Therapeutics (TTRX) Net Equity Issued and Repurchased (2024 - 2025)

Turn Therapeutics' (TTRX) quarterly Net Equity Issued and Repurchased came in at $3.2 million in Q4 2025, down 95.76% year-on-year from $75.0 million in Q4 2024, and up 959.23% quarter-over-quarter from $300000.0 in Q1 2025.

Turn Therapeutics (TTRX) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends

Turn Therapeutics' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $3.2 million for Q4 2025.

  • On a quarterly basis, Net Equity Issued and Repurchased fell 95.76% year-over-year to $3.2 million in Q4 2025; TTM through Mar 2025 was $300000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $6.9 million, up 500.45% from the prior year.
  • Net Equity Issued and Repurchased improved to $3.2 million in Q4 2025 per TTRX's latest filing, from $300000.0 in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $75.0 million in Q4 2024 and bottomed at $300000.0 in Q1 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 141.90 Mn
10 Turn Therapeutics 253.20 Mn 253.20 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 3.18 Mn
Dec 31, 2025 3.18 Mn
Mar 31, 2025 300,000.00
Mar 31, 2025 300,000.00
Dec 31, 2024 75.00 Mn
Dec 31, 2024 75.00 Mn